This is a rapidly evolving situation. PHARMAC is reviewing its processes to support the health sector and ensure people can continue to access funded medicines.
PHARMAC is easing restrictions on certain medicines to reduce hospital visits and cut the risk of highly vulnerable patients catching COVID-19.
Medicine and medical device supply
We are actively engaging with suppliers about contingency plans. We are all working to minimise any impacts of the general supply chain and manufacturing disruptions caused by international shutdowns.
COVID-19 is likely to have global impacts on medicine manufacture and supply chains for the remainder of 2020 and potentially beyond.
Other than some funded vaccines, PHARMAC itself does not purchase or hold stocks of any medicine.
Last updated: 4 June 2020
COVID-19 information for: